Viewing Study NCT03095118


Ignite Creation Date: 2025-12-25 @ 5:01 AM
Ignite Modification Date: 2026-03-03 @ 4:43 PM
Study NCT ID: NCT03095118
Status: COMPLETED
Last Update Posted: 2022-08-31
First Post: 2017-03-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Daratumumab in Treatment of PGNMID and C3 GN
Sponsor: Fernando Fervenza
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 16-004805
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators